REFERENCE
TGA - Therapeutic Goods Administration.Dabigatran (Pradaxa): risk of bleeding relating to use. Internet Document: [2 pages], 5 Oct 2011. Available from: URL: http://www.tga.gov.au
Rights and permissions
About this article
Cite this article
Increased bleeding with dabigatran warns TGA. React. Wkly. 1373, 2 (2011). https://doi.org/10.2165/00128415-201113730-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113730-00004